Open AccessIloperidone (Fanapt®): Fan or not?
Author(s) -
Uma Newton,
Tiffany-Jade Kreys
Publication year - 2011
Publication title -
mental health clinician
Language(s) - English
Resource type - Journals
ISSN - 2168-9709
DOI - 10.9740/mhc.n89390
Subject(s) - food and drug administration , drug , adverse effect , medicine , clinical trial , pharmacology , mechanism (biology) , drug administration , intensive care medicine , philosophy , epistemology
Iloperidone was approved by the Food and Drug Administration (FDA) in May of 2009. This article reviews clinically significant aspects of this new drug including: the FDA-approved indications, mechanism of action, administration, drug interactions, adverse effects, clinical trial evidence, innovative properties and place in therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom